During the past decade, Katholisches Klinikum Koblenz conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Katholisches Klinikum Koblenz" #1 sponsor was "Aesculap AG" with 6 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Alphatec Spine, Inc." with 1 trials sponsored, "ClinAssess" with 1 trials sponsored and "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Katholisches Klinikum Koblenz" #1 collaborator was "EVAMED" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator, "Medela AG" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "RTI Surgical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Katholisches Klinikum Koblenz" are "Spondylolisthesis" (3 trials), "Degenerative Disc Disease" (2 trials), "Degenerative Instability" (2 trials), "Post-discectomy Syndrome" (2 trials) and "Post-traumatic Instabilities" (2 trials). Many other conditions were trialed in "Katholisches Klinikum Koblenz" in a lesser frequency.

Most popular intervention types in "Katholisches Klinikum Koblenz" are "Device" (6 trials), "Drug" (4 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Pemetrexed" (2 trials), "5-Fluorouracil (TPF) (only until Feb 2009)" (1 trials), "Atezolizumab" (1 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Katholisches Klinikum Koblenz" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Katholisches Klinikum Koblenz". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Katholisches Klinikum Koblenz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Katholisches Klinikum Koblenz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".